PATENT CLAIM ANALYSIS

Application Number: 15962498
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "065000"]

Abstract:
The present invention describes a synergistic composition comprising of one or more statins, or one or more dipeptidyl peptidase IV (DPP IV) inhibitor or one or more biguanide antihyperglycaemic agent and a PPAR agonist of formula (Ia) for the treatment of diabetes, especially non-insulin dependent diabetes (NIDDM) or Type 2 diabetes and conditions associated with diabetes mellitus and to compositions suitable for use in such method. The invention also describes the preparation of such compositions. The present invention also relates to certain novel salts of the PPAR agonist of formula (I), processes for the preparation of these novel salts and use thereof.

Claim (Index 10):
A method for the treatment of dyslipidemia, hypertriglyceridemia and diabetes mellitus which comprising administering an effective, non-toxic and pharmaceutically acceptable amount of a compound of formula I(a) wherein \u2018M + \u2019 represents calcium, magnesium, sodium, potassium, zinc, and lithium; and one or more thiazolidinediones, to a mammal in need thereof.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 91.0
- Lexical Diversity: 1.90164
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14783336', '15594795', '13062777', '14970930', '14152282']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7483846948823621
- 35 USC 102 Novelty (BERT): 0.6108308978418607
- Combined Prediction Score: 0.734629315178312
- Mean Citation Score: 372.859212
- Max Citation Score: 594.5093
- Similarity Product: 457.8527300232053

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test